Recent Updates
Recently added Catalysts
BSX Positive Sentiment Score: 75/100

Boston Scientific announces upcoming investor conference schedule Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May. On May 13, 2025, Dan Brennan, executive vice...

Key Takeaway: Boston Scientific Corporation (NYSE: BSX) has announced its participation in two investor conferences scheduled for May 2025. Among the attendees are Dan Brennan, the CFO, and Joe Fitzgerald, the EVP and group president of Cardiology, who will engage in a Q&A session at the Bank of America's Health Care Conference. This engagement reflects their commitment to keeping investors informed and involved.

Market Sentiment Analysis

POSITIVE FACTORS

  • Boston Scientific is participating in two notable investor conferences, indicating strong investor engagement.
  • The company's leadership will be directly interacting with analysts, showing transparency and communication.
  • Live webcasts of the events provide accessibility for broader investor participation.

Full Press Release Details

MARLBOROUGH, Mass. , May 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) will participate in two upcoming investor conferences in May.
On May 13, 2025 , Dan Brennan , executive vice president and chief financial officer, and Joe Fitzgerald , executive vice president and group president, Cardiology, will participate in a 30-minute question-and-answer session with the host analyst at Bank of America's 2025 Health Care Conference. The session will begin at approximately 8:00 a.m. PT / 11:00 a.m. ET .
A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com . The replay will be available approximately one hour following the completion of the event.
About Boston Scientific Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X .
CONTACTS: Chanel Hastings Media Relations (508) 382-0288 (office) [email protected]
Jon Monson Investor Relations +1 (508) 683-5450 [email protected]
SOURCE Boston Scientific Corporation

21 %

Frequently Asked Questions

When is Boston Scientific's investor conference participation?

Boston Scientific will participate in two investor conferences in May 2025.

Who will represent Boston Scientific at the Bank of America conference?

Dan Brennan and Joe Fitzgerald will represent Boston Scientific at the event.

What time does the Q&A session at the conference start?

The Q&A session begins at approximately 8:00 a.m. PT / 11:00 a.m. ET.

Where can I watch the live webcast of the event?

The live webcast can be accessed at https://investors.bostonscientific.com.

What's Boston Scientific's focus in medical technology?

Boston Scientific focuses on innovative technologies that improve patient health globally.

Last updated: May 1, 2025